Initial experience with a novel stent-based mechanical thrombectomy device for management of acute myocardial infarction cases with large thrombus burden

ConclusionsIn AMI patients with LTB, the deployment of the novel NeVa ™ MTD seems efficient and safe. Further randomized trials are warranted to assess whether the use of the NeVa™ device in cases with LTB improves procedural and clinical outcomes.Graphical abstract
Source: Cardiovascular Intervention and Therapeutics - Category: Cardiology Source Type: research